L. Lani

Potential feasibility of Atezolizumab-Bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors.

A. Gasbarrini, V. Santi, G. Svegliati-Baroni, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Body mass index is not independently associated with increased aortic stiffness in a Brazilian population.

J. Mill, M. Baldo, S. L. Rodrigues, 2012, American journal of hypertension.

Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

A. Gasbarrini, F. Piscaglia, V. Santi, 2023, JHEP reports : innovation in hepatology.

Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care.

G. Rapaccini, C. Campani, A. Masotto, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib

T. Pressiani, F. Foschi, V. Sansone, 2024, Gastroenterology Insights.